Bruce Walton Named President and COO of Aurora Diagnostics

Bruce Walton Named President and COO of Aurora Diagnostics

PALM BEACH GARDENS, Fla. – Aurora Diagnostics announced today that Bruce Walton, the company’s Executive Vice President and Chief Operating Officer (COO) since January 2015, […]Read More

no image

Cascade Pathology Services Practice Joins Aurora Diagnostics

Acquisition builds on Aurora’s presence in Pacific Northwest PORTLAND, Ore. – Aurora Diagnostics announced today that Cascade Pathology Services Corp., a physician‐owned multi‐specialty pathology practice […]Read More

Aurora Diagnostics Completed Five Acquisitions, Important Refinancing in 2017

Aurora Diagnostics Completed Five Acquisitions, Important Refinancing in 2017

PALM BEACH GARDENS, Fla. – Aurora Diagnostics, the nation’s largest independent integrated anatomic pathology and oncology diagnostics practice, is celebrating 2017 achievements that include five […]Read More

Aurora Diagnostics Announces Acquisition of CBM Pathology of Maryland

Aurora Diagnostics Announces Acquisition of CBM Pathology of Maryland

PALM BEACH GARDENS, Fla. – Aurora Diagnostics, the nation’s largest independent integrated oncology diagnostics practice, today announced the acquisition of CBM Pathology, bringing to 31 […]Read More

Aurora Diagnostics Announces the Acquisition of the CytoPath Pathology Practice in Alabama

Aurora Diagnostics Announces the Acquisition of the CytoPath Pathology Practice in Alabama

PALM BEACH GARDENS, Fla. – Aurora Diagnostics, a leading independent pathology services and cancer diagnostics company, today announced the acquisition of CytoPath, bringing to 30 […]Read More

Christopher Rieder Joins Aurora Diagnostics as Chief Information Officer

Christopher Rieder Joins Aurora Diagnostics as Chief Information Officer

PALM BEACH GARDENS, Fla. – Aurora Diagnostics announced today that Christopher Rieder is joining the company as Chief Information Officer effective September 5. Mr. Rieder […]Read More

Aurora Diagnostics Announces the Expiration of Private Exchange Offer and Consent Solicitation for All of Its Outstanding 10.750% Senior Notes due 2018

Aurora Diagnostics Announces the Expiration of Private Exchange Offer and Consent Solicitation for All of Its Outstanding 10.750% Senior Notes due 2018

PALM BEACH GARDENS, FLORIDA–May 23, 2017– Aurora Diagnostics Holdings, LLC (the “Company”) and Aurora Diagnostics Financing, Inc. (together with the Company, the “Issuers”) announced today […]Read More

Aurora Diagnostics Announces Acquisition of Cleveland Skin Pathology Laboratory in Ohio

Aurora Diagnostics Announces Acquisition of Cleveland Skin Pathology Laboratory in Ohio

PALM BEACH GARDENS, Fla. – Aurora Diagnostics, a leading independent pathology services and cancer diagnostics company, today announced the acquisition of Cleveland Skin Pathology Laboratory […]Read More

Aurora Diagnostics Announces Acquisition of Pathology Associates of Princeton

Aurora Diagnostics Announces Acquisition of Pathology Associates of Princeton

PALM BEACH GARDENS, Fla. – Aurora Diagnostics, a leading independent pathology services and cancer diagnostics company, today announced the acquisition of Pathology Associates of Princeton, […]Read More

Page 1 of 512345»